News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant (VRX): Is Bausch & Lomb The Next To Fall?



1/18/2017 6:31:41 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Many commentators talk about Bausch & Lomb like it is the bedrock of Valeant (NYSE:VRX), but this narrative is misleading. While B&L isn't as bad as some of Valeant's other segments, it is still a relatively weak business and not immune from the continuous decline of the Valeant portfolio.

I believe Bausch & Lomb will be an area of weakness going forward. The growth in the 3rd quarter of 2016 may be an anomaly, and the segment may disappoint in the 4th quarter and onwards into 2017.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES